v3.26.1
Note 8 - Noncontrolling Interest - Clyra Medical (Tables)
3 Months Ended
Mar. 31, 2026
Notes Tables  
Schedule of Other Ownership Interests [Table Text Block]
  

Clyra Options Outstanding

  Weighted average price per share  

Weighted average remaining life

 

Balance, December 31, 2024

  1,976,863  $1.00     

Granted

  25,332  $4.50     

Balance, March 31, 2025

  2,002,195  $1.04     

Unvested

  (250,000) $0.01     

Vested Balance, March 31, 2025

  1,752,195  $1.19     
             

Balance, December 31, 2025

  3,013,692  $2.17     

Granted

  164,242  $4.44     

Balance, March 31, 2026

  3,177,934  $2.29   7.2 

Unvested

  (760,678) $4.06     

Vested Balance, March 31, 2026

  2,417,256  $1.74   8.1 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

2026

  

2025

 
  

Non Plan

  

2024 Plan

  

Non Plan

  

2024 Plan

 

Risk free interest rate

     4.30%  4.23%  4.23 - 4.58%

Expected volatility

     84%  91%  91%

Expected dividend yield

            

Forfeiture rate

            

Life in years

     10   10   10 
Warrants Outstanding for Noncontrolling Interest [Table Text Block]
  

Clyra Warrants Outstanding

  

Weighted average price per share

  

Weighted average remaining life

 

Balance, December 31, 2024

  1,183,182  $4.84     

Granted

  125,917  $6.40     

Vested Balance, March 31, 2025

  1,309,099  $4.99     
             

Balance, December 31, 2025

  1,702,496  $5.39     

Granted

  159,668  $7.50     

Expired

  (40,323) $3.72     

Vested Balance, March 31, 2026

  1,821,841  $5.61   1.7 
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Category

 

BioLargo

  

ONM

  

BLEST

  

BioLargo Canada

  

BETI

  

BEST

  

Intercompany amounts

  

Totals

 

Accounts payable

 $428  $274  $15  $119  $5  $  $(3) $838 

Accrued payroll

  10   103   94   21      10      238 

Total

                             $1,076 

Category

 

BioLargo

  

ONM

  

BLEST

  

BioLargo Canada

  

BETI

  

BEST

  

Intercompany amounts

  

Totals

 

Accounts payable

 $588  $305  $  $100   43  $  $(24) $1,012 

Accrued payroll

  10   85   73   22      9      199 

Total

                             $1,211 
Clyra Medical [Member]  
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Category

 

2026

  

2025

 

Accounts payable

 $454  $634 

Accrued dividend

  1,023   937 

Accrued payroll

  33   21 

Total

 $1,510  $1,592 
Finance Lease, Liability, to be Paid, Maturity [Table Text Block]

Year ending

    

December 31, 2026

 $112 

December 31, 2027

  150 

December 31, 2028

  150 

Total minimum lease payments

 $412 

Less imputed interest

  (76)

Total finance lease liabilities

 $336 
Clyra Medical Technologies [Member]  
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

March 31, 2026

  

March 31, 2025

 

Risk free interest rate

  4.20 - 4.36%  4.45%

Expected volatility

  35 - 39%  43%

Expected dividend yield

      

Forfeiture rate

      

Expected life in years

  10   10